Direct infection of CD34(+) progenitor cells by human cytomegalovirus: Evidence for inhibition of hematopoiesis and viral replication

被引:71
作者
Movassagh, M
Gozlan, J
Senechal, B
Baillou, C
Petit, JC
Lemoine, FM
机构
[1] HOP LA PITIE SALPETRIERE, CNRS ERS 107, LAB BIOL & THERAPY IMMUNE PATHOL, F-75651 PARIS 13, FRANCE
[2] UNIV PARIS 06, DEPT MICROBIOL, PARIS, FRANCE
关键词
D O I
10.1182/blood.V88.4.1277.bloodjournal8841277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We successfully infected fluorescence-activated cell-sorted CD34(+) cells from normal cord blood by the human cytomegalovirus (HCMV) laboratory strain Towne. An inhibitory effect of HCMV on clonogenic myeloid progenitors was observed in primary methylcellulose cultures. After an initial 7-day liquid culture of CD34(+)-infected cells, this inhibition was further amplified in secondary methylcellulose cultures, then involving both the myeloid and erythroid lineages, tinder these conditions, viral DNA was detected both in erythroid and myeloid colonies using the polymerase chain reaction (PCR), but reverse transcription PCR (RT-PCR) failed to detect viral RNA. In contrast, when CD34(+)-infected cells were maintained in liquid suspension, both immediate, early, and late transcripts were detected as soon as day 3, In addition, viral production was demonstrated in the culture supernatants, thus confirming that a complete viral cycle occurred under liquid conditions, Furthermore, by resorting cells into CD34(+) and CD34(-) fractions, we showed by RT-PCR that viral replication took place in cells still expressing CD34 antigen, whereas no RNA was found in more differentiated cells that had subsequently lost their CD34 antigen. These findings suggest that HCMV replication can occur at the early steps of progenitor differentiation and may be involved in the viral-induced myelosuppression. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:1277 / 1283
页数:7
相关论文
共 31 条
[1]  
ALFORD CA, 1990, VIROLOGY, P1981
[2]  
ALPERT G, 1985, J INFECT DIS, V15, P2
[3]  
APPERLEY JF, 1989, EXP HEMATOL, V17, P38
[4]   PANCYTOPENIA IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS - ROLE OF CYTOMEGALOVIRUS [J].
BILGRAMI, S ;
ALMEIDA, GD ;
QUINN, JJ ;
TUCK, D ;
BERGSTROM, S ;
DAINIAK, N ;
POLIQUIN, C ;
ASCENSAO, JL .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (02) :357-362
[5]  
BONNET D, 1993, BLOOD, V82, P3307
[6]   SYMPTOMATIC CONGENITAL CYTOMEGALOVIRUS-INFECTION - NEONATAL MORBIDITY AND MORTALITY [J].
BOPPANA, SB ;
PASS, RF ;
BRITT, WJ ;
STAGNO, S ;
ALFORD, CA .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (02) :93-99
[7]   IDENTIFICATION OF THE MAJOR CAPSID PROTEIN GENE OF HUMAN CYTOMEGALO-VIRUS [J].
CHEE, M ;
RUDOLPH, SA ;
PLACHTER, B ;
BARRELL, B ;
JAHN, G .
JOURNAL OF VIROLOGY, 1989, 63 (03) :1345-1353
[8]   A REVERSE POLYMERASE CHAIN-REACTION METHOD FOR DETECTION OF HUMAN CYTOMEGALOVIRUS LATE TRANSCRIPTS IN CELLS INFECTED INVITRO [J].
GOZLAN, J ;
CABURET, F ;
TANCREDE, C ;
PETIT, JC .
JOURNAL OF VIROLOGICAL METHODS, 1992, 40 (01) :1-10
[9]   HUMAN CYTOMEGALOVIRUS PRODUCTIVELY INFECTS PRIMARY DIFFERENTIATED MACROPHAGES [J].
IBANEZ, CE ;
SCHRIER, R ;
GHAZAL, P ;
WILEY, C ;
NELSON, JA .
JOURNAL OF VIROLOGY, 1991, 65 (12) :6581-6588
[10]  
KHOURY E, 1994, BLOOD, V84, P2506